About
Small Molecules
Areas of Focus
Categories
Small Molecule Pharmaceutical
Team (19)
Ali Mostajelean
Ali Mostajelean, MD
Noema Pharma
team_member
Andreas Hartmann
Andreas Hartmann, MD
Noema Pharma
team_member
Antoine Papiernik
Antoine Papiernik
Noema Pharma
team_member
Arthur Franken
Arthur Franken
Noema Pharma
team_member
Catherine Moukheibir
Catherine Moukheibir
Noema Pharma
team_member
Darren Carroll
Darren Carroll
Noema Pharma
team_member
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
9
As Collaborator
0
Total Enrollment
668
By Phase
PHASE2: 4PHASE1: 3PHASE2/PHASE3: 1
By Status
COMPLETED: 4NOT_YET_RECRUITING: 3RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06315751Lead Sponsor
Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome
PHASE2Recruiting
180 participants
Started: Sep 10, 2024 · Completed: Apr 30, 2026
NCT06297174Lead Sponsor
Bioequivalence Study of Generic Racecadotril 100 mg Capsules Under Fasting Conditions
PHASE1Not yet recruiting
44 participants
Started: Aug 26, 2024 · Completed: Sep 20, 2024
NCT06316336Lead Sponsor
Multiple Dose, Bioequivalence Study of Generic Alfuzosin Hydrochloride 10 mg Prolonged-release Tablets Under Fed Conditions
PHASE1Not yet recruiting
44 participants
Started: Jun 10, 2024 · Completed: Jun 28, 2024
NCT06308679Lead Sponsor
A Bioequivalence Study of Two Formulations of 10-mg Empagliflozin Tablets in Healthy Thai Volunteers Under Fasting Conditions
PHASE1Not yet recruiting
28 participants
Started: May 28, 2024 · Completed: Jun 7, 2024
NCT06385795Lead Sponsor
A Study of NOE-115 in Women With Vasomotor Symptoms Due to Menopause
PHASE2Completed
40 participants
Started: Apr 22, 2024 · Completed: Aug 13, 2025
Locations (1)
Headquarters
Basel, Switzerland
Map
Loading map...